As of Aug 18
| +0.09 / +3.00%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 3.88, with a high estimate of 4.50 and a low estimate of 3.50. The median estimate represents a +25.40% increase from the last price of 3.09.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.